Incanthera
Bradford, GB · 1 known investors
Find your way into Incanthera
Incanthera develops and commercializes therapeutics derived from the Institute of Cancer Therapeutics in Bradford. The company operates a direct-to-consumer model with a global network of influencers and ambassadors, targeting multi-billion dollar markets outside the US.
Investors · 1
Companies House · registry record
View on Companies House ↗- Registered name
- INCANTHERA PLC
- Company number
- 11026926
- Status
- Active
- Company type
- Public limited company
- Incorporated
- 23 Oct 2017
- Registered office
- C/O Gateley Legal, Ship Canal House, 98 King Street, Manchester, Greater Manchester, M2 4WU
- Nature of business (SIC)
- 72190 — Other research and experimental development on natural sciences and engineering
- Previous names
- PROJECT BRADFORD PLC (2017–2020)
- Accounts
- last made up to 31 Mar 2025 · next due 30 Sept 2026
- Confirmation statement
- last made up to 22 Oct 2025 · next due 5 Nov 2026
Current officers · 6
- Laura Jane Brogden — director, appointed 13 Jul 2026
- Werner Buerki — director, appointed 13 Jul 2026
- John Michael George Howes — director, appointed 10 Jun 2024
- Caroline Diana Murray — director, appointed 23 Feb 2022
- Stuart Kinnear Robertson — director, appointed 3 Jun 2026
- Simon Julian Ward — director, appointed 23 Oct 2017
Source: Companies House public register · retrieved 6 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Incanthera do?
- Incanthera develops and commercializes therapeutics derived from the Institute of Cancer Therapeutics in Bradford. The company operates a direct-to-consumer model with a global network of influencers and ambassadors, targeting multi-billion dollar markets outside the US.
- Who are Incanthera's investors?
- Incanthera's investors include IW Capital.
- Where is Incanthera headquartered?
- Incanthera is headquartered in Bradford, GB.
